Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 174

1.

Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases.

Filippou PS, Ren AH, Korbakis D, Dimitrakopoulos L, Soosaipillai A, Barak V, Frenkel S, Pe'er J, Lotem M, Merims S, Molina R, Blasutig I, Bogdanos DP, Diamandis EP.

Clin Chem Lab Med. 2018 May 16. pii: /j/cclm.ahead-of-print/cclm-2018-0139/cclm-2018-0139.xml. doi: 10.1515/cclm-2018-0139. [Epub ahead of print]

PMID:
29768245
2.

IL-35: a new immunomodulator in autoimmune rheumatic diseases.

Sakkas LI, Mavropoulos A, Perricone C, Bogdanos DP.

Immunol Res. 2018 May 11. doi: 10.1007/s12026-018-8998-3. [Epub ahead of print] Review.

PMID:
29749583
3.

The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis.

Kelepouri D, Mavropoulos A, Bogdanos DP, Sakkas LI.

J Immunol Res. 2018 Mar 5;2018:9324357. doi: 10.1155/2018/9324357. eCollection 2018. Review.

4.

Multiple hit infection and autoimmunity: the dysbiotic microbiota-ACPA connection in rheumatoid arthritis.

Sakkas LI, Bogdanos DP.

Curr Opin Rheumatol. 2018 Jul;30(4):403-409. doi: 10.1097/BOR.0000000000000503.

PMID:
29538012
5.

CpG Island Methylation Patterns in Relapsing-Remitting Multiple Sclerosis.

Sokratous M, Dardiotis E, Bellou E, Tsouris Z, Michalopoulou A, Dardioti M, Siokas V, Rikos D, Tsatsakis A, Kovatsi L, Bogdanos DP, Hadjigeorgiou GM.

J Mol Neurosci. 2018 Mar;64(3):478-484. doi: 10.1007/s12031-018-1046-x. Epub 2018 Mar 7.

PMID:
29516350
6.

Epstein-Barr Virus: In Search of a Causal or a Casual Relationship Between the Virus and the Disease?

Dardiotis E, Bogdanos DP.

Isr Med Assoc J. 2018 Feb;20(2):111-113. No abstract available.

7.

The Infectious Basis of ACPA-Positive Rheumatoid Arthritis.

Sakkas LI, Daoussis D, Liossis SN, Bogdanos DP.

Front Microbiol. 2017 Sep 27;8:1853. doi: 10.3389/fmicb.2017.01853. eCollection 2017. Review.

8.

Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis.

Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Rigopoulou EI, Scheper T, Daponte A, Meyer W, Sakkas LI, Hadjigeorgiou G, Bogdanos DP.

Sci Rep. 2017 Aug 11;7(1):7929. doi: 10.1038/s41598-017-07801-9.

9.

Disease-related autoantibody profile in patients with systemic sclerosis.

Liaskos C, Marou E, Simopoulou T, Barmakoudi M, Efthymiou G, Scheper T, Meyer W, Bogdanos DP, Sakkas LI.

Autoimmunity. 2017 Nov;50(7):414-421. doi: 10.1080/08916934.2017.1357699. Epub 2017 Jul 27.

PMID:
28749191
10.

Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives.

Sakkas LI, Mavropoulos A, Bogdanos DP.

Curr Med Chem. 2017;24(28):3054-3067. doi: 10.2174/0929867324666170530093902. Review.

PMID:
28554321
11.

IL-10-producing regulatory B cells (B10 cells), IL-17+ T cells and autoantibodies in systemic sclerosis.

Mavropoulos A, Liaskos C, Simopoulou T, Bogdanos DP, Sakkas LI.

Clin Immunol. 2017 Nov;184:26-32. doi: 10.1016/j.clim.2017.04.013. Epub 2017 May 11.

PMID:
28502678
12.

The Role of B Cells in the Pathogenesis of Systemic Sclerosis.

Sakkas LI, Bogdanos DP.

Isr Med Assoc J. 2016 Sep;18(9):516-519.

13.

IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNγ-producing T cells.

Mavropoulos A, Varna A, Zafiriou E, Liaskos C, Alexiou I, Roussaki-Schulze A, Vlychou M, Katsiari C, Bogdanos DP, Sakkas LI.

Clin Immunol. 2017 Nov;184:33-41. doi: 10.1016/j.clim.2017.04.010. Epub 2017 Apr 28.

PMID:
28461105
14.

From microbiome to infectome in autoimmunity.

Bogdanos DP, Sakkas LI.

Curr Opin Rheumatol. 2017 Jul;29(4):369-373. doi: 10.1097/BOR.0000000000000394. Review.

PMID:
28394824
15.

Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases.

Farkona S, Soosaipillai A, Filippou P, Liaskos C, Bogdanos DP, Diamandis EP, Blasutig IM.

Clin Chem Lab Med. 2017 Aug 28;55(10):1574-1581. doi: 10.1515/cclm-2016-1120.

PMID:
28343172
16.

Polymorphisms of IL12RB2 May Affect the Natural History of Primary Biliary Cholangitis: A Single Centre Study.

Wasik U, Wunsch E, Norman GL, Rigopoulou EI, Bogdanos DP, Milkiewicz P, Milkiewicz M.

J Immunol Res. 2017;2017:2185083. doi: 10.1155/2017/2185083. Epub 2017 Feb 19.

17.

Loss of C9orf72 function leads to autoimmunity.

Sakkas LI, Bogdanos DP, Kousvelari EE.

Ann Transl Med. 2017 Feb;5(3):60. doi: 10.21037/atm.2017.01.33. No abstract available.

18.

Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis.

Marou E, Liaskos C, Efthymiou G, Dardiotis E, Daponte A, Scheper T, Meyer W, Hadjigeorgiou G, Bogdanos DP, Sakkas LI.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):31-34. Epub 2017 Feb 27.

PMID:
28240591
19.

Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.

Marou E, Liaskos C, Simopoulou T, Efthymiou G, Dardiotis E, Katsiari C, Scheper T, Meyer W, Hadjigeorgiou G, Bogdanos DP, Sakkas LI.

Clin Rheumatol. 2017 Apr;36(4):863-869. doi: 10.1007/s10067-017-3553-5. Epub 2017 Jan 26.

PMID:
28124759
20.

Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.

Barouta G, Katsiari CG, Alexiou I, Liaskos C, Varna A, Bogdanos DP, Germenis AE, Sakkas LI.

Clin Rheumatol. 2017 Apr;36(4):885-894. doi: 10.1007/s10067-016-3494-4. Epub 2016 Dec 10.

PMID:
27943044

Supplemental Content

Loading ...
Support Center